Core Viewpoint - Journey Medical Corporation has promoted Ramsey Alloush to Chief Operating Officer, reflecting his leadership and critical role in the company's growth, particularly with the upcoming launch of Emrosi™ [2][3] Company Overview - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription products for dermatological conditions [3] - The company currently markets eight FDA-approved prescription drugs aimed at treating common skin conditions [3] - Founded by Fortress Biotech, Inc., Journey Medical is located in Scottsdale, Arizona and is publicly traded on NASDAQ under the ticker DERM [3] Leadership and Strategic Initiatives - Ramsey Alloush, who joined Journey Medical in 2020 as General Counsel, has over 15 years of experience in the pharmaceutical industry and has played a significant role in the company's regulatory and corporate governance matters [2] - Alloush's promotion to COO is expected to enhance operational capabilities and drive strategic initiatives that deliver value to patients, partners, and shareholders [2] - The imminent launch of Emrosi™ is seen as a pivotal moment for the company, with expectations to set a new standard of care in dermatology [2]
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer